Document:

Exhibit 10.1

ADVISORY AGREEMENT

This ADVISORY AGREEMENT (the
“Agreement”) is made this 28th day of February, 2017 by and between
by and between Global Business Strategies Inc., a Nevada corporation ("Advisor")
and NuLife Sciences Inc., a Nevada corporation (the “Company”), with an effective date of January
5, 2017 the day the Services were first provided by Advisor (the “Effective Date).

WHEREAS,
Advisor, together with its employees and agents (collectively, “Advisors Personnel”) have over 40 years of
experience in the restructuring of private and publicly-held development stage companies; the search for, identification and evaluation
of potential acquisitions; effecting multi-national mergers and acquisitions; corporate finance; identifying legal and accounting
professionals for audits and regulatory filings; supervising regulatory filings and file management,
and in performing general administrative duties for publicly-held companies; and, 

 

WHEREAS,
the Company has been utilizing Advisor’s Personnel since February 2016 to advise and assist the Company’s Board
of Directors to develop and effect a restructuring, including but not limited to (a) establishing one or more wholly owned subsidiaries,
both domestic and in international jurisdictions as necessary, through which the Company intends to de-centralize its various lines
of business (“Business Segment De-centralization”) to become a holding company
and enable it to develop and operate its core business through one or more wholly owned subsidiaries and grow the Company
through planned strategic acquisitions or Merger Transaction (as defined below), the disposition
of all or a portion of the Company’s assets (a “Sale Transaction”),
(b) creating a Non-Qualified Incentive Stock Compensation Plan (the “Stock
Plan”) for the purpose of compensation employees of and professional advisors to the Company through the issuance of the
Company’s Common Stock (“Fee Shares”) and options (“Options”) to purchase the Company’s Common
Stock (“Option Shares”), (c) establishing the standard for granting the Options, (d) the creation of a one or more
classes of Preferred Stock of the Company (the “Designation of Company Preferred”), (e) the registration of the Company’s
Fee Shares and Option Shares reserved under the Stock Plan pursuant to the Securities Act of
1933, as amended (the “Act”) by way of the filing of a Form S-8 or Form S-l Registration Statement, (f) the
evaluation of business opportunities and negotiations of acquisitions of business transactions other than the Target Acquisitions
(“Business Opportunities”, whether one or more), (g) the identification and evaluation joint venture or merger
opportunities between the Company and one or more Business Opportunities (collectively, a “Merger Transaction”). Collectively
steps (a) through (e) are referred to as the “Restructuring”, and steps (f) and (g) are referred to as “Opportunity
Evaluations”.

WHEREAS,
to accomplish the Company’s objectives it has determined that it needed to initially engage Advisors Personnel to
assist and, if necessary, to become a member of the Company’s Board of Directors and /or management team; and,

WHEREAS,
the Company now desires to retain Advisor and Advisors Personnel to assist it on a full-time basis on the terms and conditions
set forth below.

NOW,
THEREFORE, in consideration of the mutual promises, covenants and agreements contained herein, and for other good and valuable
consideration, the receipt and sufficiency of which is hereby acknowledged, the Company and Advisor agree as follows:

 

1.       Recitals
Incorporated by Reference.

The above recitals of this Agreement are incorporated
herein and made a part hereof by reference.

 

 

 

Page
1 of 10 

    	 

    	 

    

2.       Engagement:
The Services.

 

The
Company hereby retains Advisor, and to make Advisors Personnel available, to assist with the completion of the Restructuring,
Opportunity Evaluations, identifying, attracting, and evaluating business partners, investment opportunities, joint ventures and
other corporate development opportunities and other forms of Business Opportunities for the Company to acquire or invest in (each
a “Business Combination”), and particularly assist in the general and administrative functions of a publically-held
company required to file periodic reports pursuant to the Securities Exchange Act of 1934
(the “Exchange Act”), and generally to provide assistance and advice to its Board of Directors with respect
to its strategic growth plan (collectively referred to herein as the “Services”).
As governed by the terms of this Agreement, Advisor and Advisors Personnel agree to use their best efforts to provide the Services,
subject to the control, direction and supervision of the Company, commencing the Effective Date hereof and continuing through
the Initial Term or any subsequent Extension Period (as defined herein).

 

3.       Compensation.

In consideration
for the Services the Company agrees to pay, or as the case may be, to issue securities or compensate Advisor and Advisors Personnel,
as follows:

A.Services
Rendered Prior To The Effective Date. The Company and Advisor acknowledge and agree that Advisor has already provided certain
of the Services to the Company prior to the Effective Date. As an inducement for Advisor and
its Personnel to continue to work with the Company, and in particular, to use its best
efforts to effect the timely filing of the Company’s Exchange Act Form 10-Q for the period ending December 31, 2016,
the Company will issue to Advisor Fifty Five Thousand (55,000) shares of its Series A Convertible Preferred Stock (the
“Filing Bonus”) to be earned and delivered immediately upon the filing of the timely filing
of the Company’s Exchange Act Form 10-Q for the period ending December 31,2016. 

B.       Monthly
Advisory Fee. During the Initial Term of this Agreement, the Company will then pay Advisor a monthly fee (“Advisory
Fee”) equal to Eighty-Five Hundred Dollars ($8,500) per month, payable monthly on the first (lsth) day of each month beginning
January 1, 2017, payable in advance on the first day of each month through the Initial Term or Extension Period
(as defined below) hereof. The Advisory Fee, and any other fees due hereunder unless otherwise set forth herein, shall continue
until the earlier of (i) the expiration of the Initial Term or the Extension Period (as defined below), or (ii) the Termination
of this Agreement pursuant to the terms of Paragraph 12 hereof.

C.       Board
of Directors and Management Compensation. In the event the Company deems it necessary for one or more of Advisors Personnel
to become a member of the Company’s Board of Directors, the Company agrees to pay Advisor
Personnel elected to the Company’s Board of Directors Fifteen Hundred Dollars
($1,500) per month (“Directors Fee”) payable in advance on the first day of each month through die term of such
appointments). The Advisory Fee and any Directors Fee shall remain unchanged until such time
as the Company has positive cash flow, at which time, unless this Agreement is properly
terminated pursuant to paragraph 12 below, the Advisory Fee and any Directors Fee shall increase to a mutually agreeable
level, but in any event not less than that paid to the Company’s CEO as an executive officer and Director, and be payable
in cash or the Company’s Common Stock at the sole discretion of Advisor or its subject
Personnel. 

D.       Bonuses.
In the event Advisor, in his capacity as an advisor or any of Advisors Personnel it his/her capacity of corporate Director or executive
officer, or any of Advisors Personnel are successful in effecting a Business Combination or
Financing Transaction (as defined below), to the extent that bonuses are allowable under applicable federal securities rules and
regulations, the Nevada Revised Statutes and the Company’s By-laws at the time
of each such transaction:

 

Page
2 of 10 

    	 

    	 

    

(i)       where
Advisor or any of Advisors Personnel, in their capacity as an advisor or corporate executive officer, introduces a source of working
capital financing to the Company, either in the form of one or more equity investments or debt financing or other forms of corporate
financing which the Company accepts (each a “Financing Transaction”) then, separate and apart from the Advisory Fee
and the Option, the Company agrees pay Advisor, or any of Advisors Personnel as the case may be, a bonus (the “Introduction
Bonus”) equal to Five percent (5%) of the amount of funds or other financial benefit received by the Company as a result
of the Financing Transaction, before any charges or deductions for any third-party costs associated with each Financing Transaction
which shall be payable in restricted shares of the Company’s Common Stock at the prevailing Bid price of the Company’s
Common Stock upon the announcement of such Financing Transaction, to be issued out of the Stock Plan. A Financing Transaction not
introduced by Advisor or Advisors Personnel, as the case may be, is exempt for the duty to
pay Advisor, or Advisors Personnel, as the case may be, an Introduction Bonus. 

(ii)       where
Advisor or any of Advisors Personnel, in their capacity as an advisor or corporate Director or executive officer, is successful
in effecting a Business Combination on behalf of the Company and a Business Opportunity introduced
by Advisor or any of Advisors Personnel, as the case may be, in their capacity as an advisor or corporate executive officer,
then, unless otherwise mutually agreed between Advisor, or Advisors Personnel, as the case may be, and the Company in writing,
in addition to any other fees required pursuant to this Agreement, Advisor, or Advisors Personnel, as the case may be, shall be
entitled to a Business Combination Bonus. Such Business Combination Bonus shall be equal to Five percent (5%) of the value of each
Business Opportunity introduced by Advisor, and acquired by the Company, or where an affiliate
of the Company acquires an equity interest or otherwise derives some economic benefit.
The Business Combination Bonus shall be payable in restricted shares of the Company’s Common Stock at the prevailing
Bid price of the Company’s Common Stock upon the announcement of the Company entering into an agreement
or Letter of Intent with such Business Opportunity , and issued out of the Stock Plan upon the Closing of such Business
Combination. A Transaction Fee not introduced by Advisor, or Advisors Personnel, as the case may be, is exempt for the duty to
pay an Introduction Bonus.

The Company and Advisor
mutually agree that, in the event Advisor or Advisor’s Personnel receives shares of the
Company’s Common Stock in lieu of cash, for purposes of any “profit” computation under Section 16(b) of the Exchange
Act, the price paid for such shares, and the cost basis of the of the Option Shares,
will be the net sales price that Advisor and/or Advisor’s Personnel receives in the subsequent sale of such shares.

Notwithstanding
anything in this Agreement to the contrary, the terms of this paragraph shall survive this Agreement
for three (3) years following the later of the expiration or termination hereof,
and any Transaction Fee or Introduction Bonus related to Business Combination or Financing
Transaction effected during the Survival shall be paid to pursuant to Advisor under the terms of this paragraph.

 

 

 

 

 

Page
3 of 10 

    	 

    	 

    

4.       Term
of Engagement

 

This
Agreement shall have an initial term of Twenty Four (24) months (the “Initial Term”) and, subject to paragraph
12 below, shall terminate upon the earlier of (a) January 5, 2019 (the “Termination
Date”). This Agreement shall be terminated earlier that the Termination Date upon (a)
Advisor’s resignation by written notice as set forth in paragraph 12 below, or (b) termination by
action of the Company’s Board of Directors and shareholders, respectively, for Cause, as defined below. Unless terminated
prior to the Termination Date for Cause, or (a) or (b) above, the Initial Term of this
Agreement shall automatically be extended for consecutive six (6) month terms (each an “Extension Period”) until either
Advisor or the Company serves written notice to terminate to the other party at least
Thirty (30) days prior to the expiration of any Extension Period. 

 

5.       Time
Obligation

Advisor
and Advisors Personnel shall devote not less than Forty (40) hours per month, as necessary from day-to-day or week-to-week,
excluding attending properly noticed meetings of the Board of Directors if one of Advisor’s Personnel is appointed a member
of the Company’s Board of Directors. The Company understands, acknowledges and agrees that Advisor and Advisors Personnel
serve as Advisors and as officers and/or directors, and periodically provide similar services for other companies (“Third
Party Clients “) which require their professional time, and Advisor and Advisors Personnel shall use their best efforts to
schedule their time and travel commitments related to such Third Party Clients to accommodate
the Company; provided however, failing to reschedule or otherwise re-arrange his commitments
to the Third Party Clients shall not be a cause for Termination (as defined herein)
nor shall Advisor or Advisors Personnel be penalized in any way as a result of his inability to resolve any conflicts in
their scheduling which precludes them from attending, either in person or otherwise, any Advisory or Board of Director meetings
- see ’’Potential Conflicts” in paragraph 10.

 

6.       Indemnification

Advisor shall
not be liable to the Company or any of its shareholders, and the Company shall indemnify and hold Advisor harmless from and against
all demands, claims, actions, losses, damages, liabilities, costs and expenses, including without limitation, interest, penalties
and attorneys' fees and expenses asserted against or imposed or incurred by him, and to pay related attorney’s
fees incurred by Advisor by reason of or resulting from litigation to which Advisor is named a party defendant relating in any
way to any action by Advisor, or omission, in the course of or connected with rendering the Services, including but not
limited to losses that may be sustained in any corporate act undertaken by the Company as a result of advice provided by Advisor
(“Indemnification”). This covenant is provided by the Company as an inducement for Advisor
to enter into this Agreement. Excluded from Indemnification under this Agreement is the Advisor’s willful acts or
omissions which may give cause to bring suit against the Company’s Board of Directors
for breach of fiduciary duty or fraud, or such other action that may be against public policy for the Company to waive,
release or indemnify against.

 

6.       Costs
and Expenses

All third
party and out-of-pocket expenses incurred by Advisor in the performance of the Services shall be paid by the Company,
or if paid by Advisor on behalf of the Company then reimbursed by the Company. Reimbursement
of costs and expenses shall be made within ten (10) days of receipt by the Company of Advisor’s written request for
reimbursement; provided, however, that the Company must approve in advance all such
expenses in the aggregate in excess of $500 in any one (1) month. 

 

Page
4 of 10 

    	 

    	 

    

7.       Use
of Confidential Information.

Neither Advisor
nor the Company shall use the Confidential Information in any respect to circumvent the other
party or parties in any effort, directly or indirectly, to effect a transaction of any kind using Confidential Information
obtained from the other party or parties hereto (a “Circumvented Transaction”).
In this regard, the Company and Advisor hereby mutually agree that neither they nor any of their respective clients or customers,
or persons or entities related directly or indirectly to such party shall, shall directly or indirectly:

		A.	Attempt in any manner to circumvent, avoid or bypass the Originating Party in any transaction
between the Non-Originating Party and its clients, suppliers, brokers, agents, customers
or distributors in an effort to avoid the payment of, or decrease the amount of fees
or other compensation which would have otherwise been payable to the Originating Party had the Non-Originating Party included
the Originating Party in such transaction; or, 

		B.	Attempt in any manner to commercially exploit or circumvent the Originating Party’s existing
or proposed business concepts, plans and/or business contacts, or any attempt by the Non-Originating Party to contact, negotiate
with or enter into any contract or transaction with the Originating Party's clients or business prospects (each a “Circumvented
Transaction”) without first obtaining such Originating Party's written approval. 

It is mutually
understood and agreed that if the Originating Party decides to grant its consent to any proposed Circumvented Transaction, the
Originating Party shall have the right (but not the obligation) to condition such consent upon the execution of a written agreement
with the Disclosing Party concerning remuneration to be paid to the Originating Party related
to each such Circumvented Transaction.

 

8.       Agreement
Not To Circumvent.

In the course
of this Agreement, both the Company and Advisor will be disclosing certain Information which the other party would not otherwise
have or be aware of if not disclosed pursuant to this Agreement or available in the public domain (“Confidential Information”).
It is understood and agreed by both the Company and Advisor that all Confidential Information, whether written or verbal, disclosed
by the Company and Advisor to each other shall be considered Confidential Information shall
not in any manner be disclosed by the Non-Originating Party to any party not parties to this Agreement without the written consent
of Originating Party. 

 

9.       Place
of Services

Unless otherwise
mutually agreed by Advisor and the Company, the Services provided by Advisor and Advisors Personnel hereunder will be performed
from both the offices of the Company or Advisor, or such other location, as may be required to effectively provide the Services.
Advisor and the Company mutually agree that failing to mutually agree on where the Services shall be provided, the default location
shall be Advisors office.

 

10.       Potential
Conflicts

The
Company acknowledges that Advisor or Advisors Personnel may currently be providing, or at any time during the Initial Term
provide, similar services for other companies relating to some or all of the same services to be provided to the Company pursuant
to this Agreement (“Multiple Representation”) and, provided such Multiple Representation
does not result in the breach of Advisor’s covenant to the Company not to disclose any Confidential Information of the 

Page 5 of 10

    	 

    	 

    

Company, except
as required by law, the Company agrees to waive any and all claims that may arise in their favor in the event such Multiple Representation
provided such Multiple Representation is not in a conflict with the Company’s current business or planned expansion. The
Company understands that Advisor is relying explicitly on the foregoing provision and waiver in entering into this Agreement.

 

11.       Advisor
an Independent Contractor

Advisor
and Advisors Personnel are providing the Services jointly and severally as an independent contractor and not as an employee of
the Company or of any entity affiliated with the Company, unless such relationship is modified
by a separate written agreement. If the Company or any of its affiliated entities are required to pay or withhold any taxes
or make any other payment with respect to fees payable to Advisor as an independent contractor, Advisor will reimburse
the Company or the affiliated entity in full for taxes paid, and permit the Company to make
deductions for taxes required to be withheld from any sum due Advisor. The Company and Advisor mutually agree that the status
of Advisor and Advisors Personnel, each as independent contractors, shall remain in place in the event that any one of Advisors
Personnel accepts a position on the Company’s Board of Directors and/or becomes an executive
officer, in which case only the Director and Management Fee (as Defined below) shall be consider “Salary” and
be subject to Form W-2.

 

12.       Termination

 

This
Agreement will terminate upon the earlier of (a) on the second anniversary of the Effective Date, or (b) thirty (30) days
following receipt by Advisor of written notice by the Company to Advisor to terminate Advisor
for Cause, or (c) thirty (30) days following receipt by the Company of written notice
by Advisor to terminate this Agreement, for any reason. For the purpose of this Agreement the term “Cause” shall
mean:

 

A.       As
to Advisor;

i)       Advisor,
through Advisors Personnel, is unable to provide the Services as set forth herein for thirty (30) consecutive business days because
of illness, accident, or other incapacity; or 

ii)       Advisor
willfully breaches or neglects the duties as reasonably requested by a majority of the members of the Company’s Board
of Directors;

iii)       Advisor
breaches a material term of this Agreement; or

iv)       Advisor
files a petition in a court of bankruptcy, or is adjudicated a bankrupt; or, 

 

v)       Advisor
is convicted of or enters a plea of guilty or nolo contendere to a felony or misdemeanor involving fraud, embezzlement,
theft or dishonesty or other criminal conduct.

 

B.       As
to the Company:

i)       If
the Company breaches this Agreement or fails to (1) make any payments to Advisor of the Advisory Fee or any other fees as required
pursuant to this Agreement, or (2) fails to provide information reasonably requested by Advisor
in the ordinary course of providing the Services; or 

Page
6 of 10 

    	 

    	 

    

ii)       If
the Company ceases business, or if the Company sells a controlling interest to a third party,
or agree to a consolidation or merger of itself with or into another corporation, or
sells substantially all of its assets to another corporation, entity or individual
not introduced by Advisor; or 

 

iii)       If
the Company has a receiver appointed for its business or assets, or otherwise becomes insolvent or unable to timely satisfy its
obligations in the ordinary course of business, or if either the Company makes a general assignment for the benefit of creditors,
has instituted against it any bankruptcy proceeding for reorganization for rearrangement of its financial affairs, files a petition
in a court of bankruptcy, or is adjudicated a bankrupt; or 

 

iv)       If
any of the disclosures made by the Company herein, or subsequent hereto, are determined to be materially false or misleading.

 

In the event this
Agreement is terminated prior to the Termination Date by the Company for Cause, the Company shall pay Advisor, within Thirty (30)
days following the effective date of termination, all unreimbursed expenses together with any
unpaid Advisory Fee, Transaction Fee or Introduction Bonus earned and accrued, up to and including the effective Termination
Date (collectively, “Earned Compensation”).

In
the event this Agreement is terminated prior to the Termination Date by the Company without Cause, the Company agrees to deliver
to Advisor all Earned Compensation which would otherwise be due to Advisor through the second anniversary date of his Agreement
or the Extension Period, if any.

13.
       Representations and Warranties of the Company

The Company represents and warrants to
Advisor that:

		A.	Corporate Existence. The Company is a corporation duly organized, validly existing,
and in good standing under the laws of the State of Nevada, with power to own property and carry on its business as it is now being
conducted. 

		B.	No Conflict. This Agreement has been duly executed
by the Company and the execution and performance of this Agreement will not violate, or result in a breach of, or constitute
a default in any agreement, instrument, judgment, decree or order to which the Company is
a party or to which the Company is subject, nor will such execution and performance constitute a violation or conflict of any fiduciary
duty to which the Company is subject.

		C.	Full Disclosure. The information concerning the Company
provided to Advisor pursuant to this Agreement is, to the best of the Company's knowledge and belief, complete and accurate in
all material respects and does not contain any untrue statement of a material fact or omit to state a material fact required
to make the statements made, in light of the circumstances under which they were made, not misleading.

		D.	Date of Representations and Warranties. Each of the
representations and warranties of the Company set forth in this Agreement is true and
correct at and as of the date of execution of this Agreement.

 

 

 

 

 

Page
7 of 10 

    	 

    	 

    

14.       Miscellaneous

 

		A.	Authority. Advisor and those executing this Agreement on behalf of the Company represent
that they are duly authorized to do so, and that each has taken all requisite action required by law or otherwise to properly allow
such signatories to execute this Agreement.

		B.	Subsequent Events. Advisor and the Company each agree to notify the other parties if, subsequent
to the date of this Agreement, one of the parties incurs obligations which could compromise its efforts and obligations under this
Agreement.

		C.	Amendment. This Agreement may be amended or modified at any time and in any manner only
by an instrument in writing executed by the parties hereto.

		D.	Further Actions and Assurances. At any time and from time to time, each party hereto agrees,
at its expense, to take such action and to execute and deliver documents as may be reasonably requested or necessary to effectuate
the purposes of this Agreement.

		E.	Waiver. Any failure of any party to this Agreement
to comply with any of its obligations, agreements, or conditions hereunder may be waived in writing by the party to whom such compliance
is owed. The failure of any party to this Agreement to enforce at any time any of the provisions of this Agreement shall in no
way be construed to be a waiver of any such provision or a waiver of the right of such party thereafter to enforce each and every
such provision. No waiver of any breach of or non-compliance with this Agreement shall be held to be a waiver of any other or subsequent
breach or noncompliance.

 

		F.	Assignment. Neither this Agreement nor any right created by it shall be assignable by any
party hereto without the prior written consent of the other party.

		G.	Notices. Any notice or other communication required or permitted by this Agreement must
be in writing and shall be deemed to be properly given when delivered in person to an
officer of the other party when deposited for transmittal by certified or registered mail, postage
prepaid, or when sent by facsimile, “email” or other electronic transmission with proof of delivery, addressed
as follows:

In the case of the Company:

NuLife Sciences Inc

1031 Calle Recodo,
Ste B San Clemente CA 92673

Telephone; 1.949.973.0684 Email: info@,nulifesciences.us

In the case of Advisor:

Fred
G. Luke 

2618 San Miguel, Suite 203

Newport
Beach, CA92660

Telephone;
1.949.400.1415 

Email:
hike, gmai@gmail.com

 

or
to such other person or address designated in writing subsequent to the date hereof by the Company or Advisor to receive
notices.

 

 

 

Page
8 of 10 

    	 

    	 

    

		H.	Headings. The sections and subsection headings in this Agreement are inserted for convenience
only and shall not affect in any way the meaning or interpretation of this Agreement. 

		I.	Governing Law. This Agreement shall be governed by and
construed in accordance with the laws of the State of California, applicable to the performance and enforcement of contracts
made within such state, without giving effect to the law of conflicts of laws applied thereby.
In the event that any dispute shall occur between the parties arising out of or resulting from the construction, interpretation,
enforcement or any other aspect of this Agreement, the parties hereby agree to accept the
exclusive jurisdiction of the Courts of the State of California sitting in and for the County of Orange. In the event either
party shall be forced to bring any legal action to protect or defend its rights hereunder, then
the prevailing party in such proceeding shall be entitled to reimbursement from the non-prevailing party of all fees, costs and
other expenses (including, without limitation, the actual expenses of its attorneys) in bringing or defending against such
action.

 

		J.	Limitation of Liability. Notwithstanding an applicable
statute of limitations, all claims or causes of action must be brought by either party
within six months from the date of such breach of this Agreement. Any liability of
Advisor for breach of this Agreement and for any and all other claims and causes of action against Advisor shall not exceed
the total compensation paid to Advisor under this Agreement.

		K.	Termination of Anv Prior Agreements. Effective the date hereof all rights of the Company
and Advisor related to any other agreement entered into between the Company and Advisor prior to the Effective Date hereof,
whether written or oral, is hereby terminated.

		L.	Time is of the Essence. Time is of the essence of this Agreement and of each and every provision
hereof.

		M.	Binding Effect. This Agreement shall be binding upon
the parties hereto and inure to the benefit of the parties, their respective heirs, administrators, executors, successors,
and assigns. 

		N.	Entire Agreement. This Agreement contains the entire agreement between the parties hereto
and supersedes any and all prior agreements, arrangements, or understandings between the parties relating to the subject matter
of this Agreement. No oral understandings, statements, promises, or inducements contrary to the terms of this Agreement exist.
No representations, warranties, covenants, or conditions, express or implied, other than as set forth herein, have been made by
any party.

		O.	Severability. If any part of this Agreement is deemed
to be unenforceable the balance of the Agreement shall remain in full force and effect.

		P.	Counterparts: Facsimile. An original of this Agreement
may be executed simultaneously in three or more executed facsimile, telecopy or other electronic reproductive counterparts,
each of which shall be deemed an original, or facsimile, telecopy or other electronic reproductive
counterparts, shall constitute one and the same instrument, and delivery of such shall be considered valid, binding
and effective for all purposes. At the request of any party hereto, all parties agree to execute an original of this instrument
as well as any facsimile, telecopy or other reproduction hereof.

		Q.	Consolidation or Merger. Subject to the provisions
hereof, in the event of a sale of the stock, or substantially all of the stock of the Company, or consolidation or merger
of the

Page
9 of 10 

    	 

    	 

    

Company
with or into another corporation or entity, or the sale of substantially all of the operating
assets of the Company to another corporation, entity or individual, die Company’s rights and obligations under this
Agreement to its successor-in-interest shall be deemed to have acquired and assumed by such
successor-in-interest; provided, however, that in no event shall the duties and services of Advisor provided for herein, or the
responsibilities, authority or powers commensurate therewith, change in any material respect as a result of such sale of stock,
consolidation, merger or sale of assets. 

 

IN
WITNESS WHEREOF, the parties have executed this Agreement effective the date first written above.

The "Company"

NuLife Sciences Inc.

 

 

By:
_______________________

Name: Sean Clarke Title: Secretary

 

"Advisor
" 

Global Business Strategies Inc.

 

 

By:
_______________________

Name: Fred Luke Title: President

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Page
10 of 10Exhibit 10.2

STOCK PURCHASE AGREEMENT

 

THE STOCK PURCHASE
AGREEMENT (“Agreement”) is made and entered into in duplicate this 28th day of February, 2017, by and between Sean
Clarke, a resident of Orange County, California (“Seller”) and Steve Strasser, an individual residing in Salt Lake
County, Utah (“Purchaser”).

 

A. The Seller owns
and desires to sell certain shares of common stock NuLife Sciences Inc., a Nevada corporation (the “Company”).

 

B. The Purchaser
desires to purchase shares of common stock of the Company from the Seller, on the terms and subject to the conditions specified
in this Agreement.

 

NOW, THEREFORE, IN CONSIDERATION
OF THE RECITALS SPECIFIED ABOVE THAT SHALL BE DEEMED TO BE A SUBSTANTIVE PART OF THIS AGREEMENT, AND THE MUTUAL COVENANTS, PROMISES,
UNDERTAKINGS, AGREEMENTS, REPRESENTATIONS AND WARRANTIES SPECIFIED IN THIS AGREEMENT AND OTHER GOOD AND VALUABLE CONSIDERATION,
THE RECEIPT AND SUFFICIENCY OF WHICH ARE HEREBY ACKNOWLEDGED, WITH THE INTENT TO BE OBLIGATED LEGALLY AND EQUITABLY, THE PARTIES
DO HEREBY COVENANT, PROMISE, AGREE, REPRESENT AND WARRANT AS FOLLOWS:

 

		1.	Purchase of Shares.

 

On the terms and subject
to all of the conditions specified by the provisions of this Agreement and upon the performance by each of the parties of their
respective obligations created by the provisions of this Agreement, the Seller hereby forever and irrevocably sells, assigns, transfers,
surrenders, conveys, delivers and sets over to the Purchaser, and Purchaser hereby purchases the Shares from the Seller, One Hundred
Thousand (100,000) shares of the Company (the “Shares”).

 

		2.	Consideration.

 

As the consideration for
the Seller's surrender and sale, and the Purchaser’s purchase, of the Shares, the Purchaser shall pay and deliver to One
Thousand Dollars ($1,000.00).

 

		3.	Seller's Representations, Warranties and Covenants.

 

The Seller represents and
warrants to the Purchaser and covenants with the Purchaser the following, the truth and accuracy of each of which shall constitute
a condition precedent to the obligations of the Purchaser pursuant hereto:

 

3.1 Validity
of Agreement. This Agreement is valid and obligates the Seller. The Seller has full and complete power and authority to sell
the Shares, as contemplated by the provisions of this Agreement.

 

3.2 Share
Ownership. The Seller is the owner, free and clear of any encumbrances, of the Shares. The Seller has full and complete right
and authority to transfer, sell, surrender, assign and convey the Shares to the Purchaser. The Shares may be subject to the restrictions
embodied in Rule 144.

    	 

    	 

    

 

 

3.3 Brokerage
and Finder's Fees. The Seller has not incurred any liability to any broker, finder or agent for any brokerage fees, finder's
fees or commissions with respect to the transaction contemplated by the provisions of this Agreement.

 

3.4 Voluntary
Nature of Transaction. The sale by the Seller to the Purchaser of the Shares is made freely and voluntarily by the Seller.
The Seller, in selling the Shares to the Purchaser, is not acting under duress, menace, threat or undue influence.

 

4.                 
Purchaser’s Representations and Warranties.

 

The Purchaser represents
and warrants to the Seller and covenants with the Seller the following, the truth and accuracy of each of which shall constitute
a condition precedent to the obligations of the Seller pursuant hereto:

 

4.1       Brokerage
and Finder's Fees. Purchaser has not incurred any liability to any broker, finder or agent for any brokerage fees, finder's
fees or commissions with respect to the transaction contemplated by the provisions of this Agreement.

 

4.2       Voluntary
Nature of Transaction. Purchaser acknowledges that the purchase of the Shares contemplated by this Agreement is not being made
under duress, menace, threat or undue influence.

4.3       Authority.
The Buyer has all necessary power and authority to execute, deliver and perform this Agreement and to consummate the transactions
provided for herein. This Agreement has been duly executed and delivered by the Buyer and constitutes a valid and binding obligation
of the Buyer enforceable in accordance with its terms. The execution, delivery and performance of this Agreement by the Buyer does
not and will not violate any provision of any law, regulation or order, or result in the breach of, or constitute a default under,
any material agreement or instrument to which any Buyer is a party or by which the Buyer may be bound or affected; and, 

4.4       No
Solicitation. The Buyer's purchase of the Shares hereunder has not been solicited by means of general solicitation or by advertisement;
and,

 

4.5       Private
Transaction. Buyer understand that the sale of Shares is not being registered on the basis that this purchase and sale is exempt
from registration under applicable securities rules and regulations, including but not limited to the US Securities Act of 1933,
as amended (the “Act”), and other applicable US and foreign state and federal rules and regulations. Further, Purchaser
is acquiring the Shares for its own account and investment purposes and not as a nominee and not with a view to the distribution
thereof. Purchaser understands that it must bear the economic risk of this investment indefinitely unless the Shares are registered
pursuant to the Act, or an exemption from such registration is available; and,

 

    	 

    	 

    

 

4.6       Suitability.
By reason of its business or financial experience, or that of its professional advisors, Purchaser has the capacity to protect
its interests in connection with the purchase of securities contemplated by this Agreement and it has the ability to bear the economic
risk (including the risk of total loss) of its investment. Further, Purchaser is an “accredited investor” within the
meaning of Rule 501 of Regulation D of the Act, as presently in effect. Further, Purchaser represents that, by virtue of its respective
economic bargaining power or otherwise, it has had access to or have been furnished with, prior to or concurrently with Closing,
the same kind of information that would be available in a registration statement under the Act should registration of the Shares
issued pursuant to this Agreement have been necessary, and it has had the opportunity to ask questions of and receive answers from
Seller officers and directors, or parties acting on their behalf, concerning the business of Seller and that Purchaser has had
the opportunity to obtain any additional information, to the extent that Seller possesses such information or can acquire it without
unreasonable expense or effort, necessary to verify the accuracy of information obtained or furnished by Seller and the Company’s
financial condition; and,.

4.7       Entity
not Formed For This Transaction. Buyer affirms that it is a not an entity not formed not solely for the purpose of acquiring
the Shares; and,

 

4.8       Buyers
Due Diligence. Buyer acknowledge that it has conducted, or has been afforded the opportunity to conduct an investigation of
the Company and has been offered the opportunity to ask representatives of the Company questions about the Company’s financial
condition and proposed business, and that Buyer has obtained such available information as Buyer has requested, to the extent Buyer
have deemed necessary, to permit it to fully evaluate the merits and risks of an investment in the Shares. Buyer is satisfied as
to all inquiries that Buyer has concerning the Company and its business activities, and the purchase of the Shares; and,

 

4.9       No
Regulatory Review. Buyer understand that no US or foreign federal or state agency has made any finding or determination as
to the fairness of the terms of an investment in the Shares, or any recommendation for or endorsement of the Shares being purchased
pursuant to this Agreement; and,

4.10       Buyers
Right To Terminate Upon Purchasers Default.. Buyer acknowledges that Seller, in his sole discretion, shall have the right to
terminate this Agreement at any time, in whole or in part, if any Buyer is in default under any of the terms hereof prior to Closing.

5.                 
Entire Agreement.

This
Agreement constitutes the complete understanding between the parties hereto with respect to the subject matter hereof, and no alteration,
amendment or modification of any of the terms and provisions hereof shall be valid unless made pursuant to an instrument in writing
signed by each party. This Agreement supersedes and terminates any and all prior agreements or understandings between the parties
regarding the subject matter hereof. 

    	 

    	 

    

 

 

6.                 
Governmental Rules and Regulations. The purchase
of the Shares is subject to any and all present and future orders, rules and regulations of any duly constituted authority having
jurisdiction of that purchase.

 

7.                 
Severability. In the event any part of this Agreement,
for any reason, is declared to be invalid, such decision shall not affect the validity of any remaining portion of this Agreement,
which remaining portion shall remain in full force and effect as if this Agreement had been executed with the invalid portion thereof
eliminated, and it is hereby declared the intention of the parties to this Agreement that they would have executed the remaining
portion of this Agreement without including any such part, parts, or portion which, for any reason, may be hereafter declared invalid.

 

8.                 
Further Assurance. Each party to this Agreement hereby
agrees to take any and all action necessary or appropriate to execute and discharge its responsibilities and obligations created
pursuant to the provisions of this Agreement and to further effectuate and carry out the intents and purposes of this Agreement
and the transactions contemplated hereby.

 

9.                 
Notices. All notices and other communications hereunder
shall be in writing and shall be sent by prepaid first class mail to the parties at the following addresses, as amended by the
parties with written notice to the other:

 

If To Seller:

Sean Clarke

225 Avenida Monterey, Unit D

San Clemente, CA 92672

Tel: 949-973-0684

Email: jackson.sean101@yahoo.com

 

If to Purchaser:

 

Steve Strasser,

1416 Perrys
Hollow

Salt Lake
City, Utah 84103

Tel: 801-381-3821

Email: s.strasser@comcast.net

 

10.             
Execution in Counterparts. This Agreement may be
executed in several counterparts and, when so executed, it shall constitute one agreement binding all parties to this Agreement,
notwithstanding that all parties to this Agreement are not signatory to the original and same counterpart. 

 

11.             
Venue and Jurisdiction. Any dispute regarding the
terms and provisions of this Agreement shall be litigated in the appropriate court located in Orange County, California. All parties
hereto specifically waive any challenge to jurisdiction.

 

    	 

    	 

    

 

IN WITNESS WHEREOF,
the parties to this Agreement have executed this Agreement effective the date first above written.

 

(“Seller”)

Sean Clarke

 

 

_______________________________

.

 

“Purchaser”

Steve Strasser,

 

 

______________________________

 

 

 

 

 

    	 	1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00269-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00269-of-00352.parquet"}]]